Skip to main content
Equibles

Alicia Olivo

General Counsel

Neogenomics Inc (NEO)

Equibles does not estimate personal net worth.

Get an email with a short summary when Neogenomics Inc publishes a filing, an earnings call transcript or a press release.

Get NEO alerts

About Alicia Olivo

Alicia Olivo is recorded as General Counsel at Neogenomics Inc (NEO). The newest filing on record that lists Alicia Olivo as General Counsel at Neogenomics Inc (NEO) is dated April 6, 2026. The proxy statement of Neogenomics Inc reports total compensation of $3,049,999 for Alicia Olivo in fiscal 2025, including a base salary of $522,500. Disclosed compensation is on record for 4 fiscal years. Alicia Olivo has spoken on 2 earnings calls across 1 company, most recently for Neogenomics Inc on July 29, 2024. Neogenomics Inc is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Neogenomics Inc includes Chris Smith (CEO and Board Member), Christopher Smith (CEO and Board Member), Tony Zook (CEO, Chairman and Board Member) and 7 others.

Alicia Olivo on recent calls

“I mean I'm not sure I understand your question, if it's around goodwill impairment or something like that, which we're not going to address.”
General Counsel, Neogenomics Inc Q2 FY2024 Earnings Call ·
“So there are 3 pathways that we kind of alluded to in our prepared remarks. One is obviously the litigation, and we see that via the district court matter as well as our IPRs that were filed against both patents that are asserted by Natera.”
General Counsel, Neogenomics Inc Q1 FY2024 Earnings Call ·

Affiliation history

  • Neogenomics Inc (NEO)

    General Counsel

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 6, 2026

Company network

Leadership on record at Neogenomics Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Neogenomics Inc (NEO) $522,500 $3,049,999
2024 Neogenomics Inc (NEO) $512,672 $2,236,859
2023 Neogenomics Inc (NEO) — —
2022 Neogenomics Inc (NEO) — —

Recent activity